These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30660754)

  • 1. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
    Quansah E; Zetterström TSC
    Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates.
    Zhang X; Talpos J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG
    Neurotoxicol Teratol; 2021; 87():107017. PubMed ID: 34265415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Methylphenidate on the Dopamine Transporter and Beyond.
    Zetterström TSC; Quansah E; Grootveld M
    Curr Top Behav Neurosci; 2022; 57():127-157. PubMed ID: 35507284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability.
    Markowitz JS; Zhu HJ; Patrick KS
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):648-54. PubMed ID: 24261661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats.
    Quansah E; Ruiz-Rodado V; Grootveld M; Zetterström TSC
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):513-528. PubMed ID: 29478746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventral striatum supports Methylphenidate therapeutic effects on impulsive choices expressed in temporal discounting task.
    Martinez E; Pasquereau B; Drui G; Saga Y; Météreau É; Tremblay L
    Sci Rep; 2020 Jan; 10(1):716. PubMed ID: 31959838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of methylphenidate after long-term exposure in nonhuman primates.
    Zhang X; Berridge MS; Apana SM; Slikker W; Paule MG; Talpos J
    Neurotoxicol Teratol; 2023; 97():107173. PubMed ID: 36893929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
    Simchon Y; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):714-20. PubMed ID: 20493667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.
    Sadasivan S; Pond BB; Pani AK; Qu C; Jiao Y; Smeyne RJ
    PLoS One; 2012; 7(3):e33693. PubMed ID: 22470460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.
    Calipari ES; Ferris MJ; Melchior JR; Bermejo K; Salahpour A; Roberts DC; Jones SR
    Addict Biol; 2014 Mar; 19(2):145-55. PubMed ID: 22458761
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
    Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats.
    Di Miceli M; Derf A; Gronier B
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study.
    Markowitz JS; DeVane CL; Pestreich LK; Patrick KS; Muniz R
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):687-98. PubMed ID: 17201613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.
    McLaughlin G; Morris N; Kavanagh PV; Power JD; Dowling G; Twamley B; O'Brien J; Hessman G; Murphy B; Walther D; Partilla JS; Baumann MH; Brandt SD
    Drug Test Anal; 2017 Mar; 9(3):347-357. PubMed ID: 28103426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
    Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
    Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
    Calipari ES; Ferris MJ; Siciliano CA; Jones SR
    ACS Chem Neurosci; 2015 Jan; 6(1):155-62. PubMed ID: 25474655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.